Tin tức & Cập nhật
Xem bài viết Nhãn khoa
Xem
Chỉ hiển thị Multimedia

OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
bởiAudrey Abella
In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.
24 May 2022








